A review of linezolid: the first oxazolidinone antibiotic.
about
Current updates on oxazolidinone and its significanceHigh plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia.Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus.Risk of serotonin syndrome with concomitant administration of linezolid and serotonin agonists.Linezolid treatment for gram-positive infections: a retrospective comparison with teicoplanin.Methicillin-resistant Staphylococcus aureus USA300 clone as a cause of Lemierre's syndrome.Rapid emergence of resistance to linezolid during linezolid therapy of an Enterococcus faecium infection.Efficacy of linezolid, teicoplanin, and vancomycin in prevention of an experimental polytetrafluoroethylene graft infection model caused by methicillin-resistant Staphylococcus aureus.Virulence-suppressing effects of linezolid on methicillin-resistant Staphylococcus aureus: possible contribution to early defervescenceDesign, Synthesis, and Identification of Silicon Incorporated Oxazolidinone Antibiotics with Improved Brain Exposure.Update on linezolid: the first oxazolidinone antibiotic.Pharmacoeconomics of treatment with the newer anti-Gram-positive agents.Linezolid: a new antibiotic for newborns and children?Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin?Linezolid: effectiveness and safety for approved and off-label indications.Vascular graft infection by Staphylococcus aureus: efficacy of linezolid, teicoplanin and vancomycin systemic prophylaxis protocols in a rat modelUpdate on the appropriate use of linezolid in clinical practiceSynthesis and antibacterial activity of novel curcumin derivatives containing heterocyclic moiety.Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience.Emerging drugs for complicated skin and skin-structure infections.Resistant pathogen-associated skin and skin-structure infections: antibiotic options.An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy.Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans.An azido-oxazolidinone antibiotic for live bacterial cell imaging and generation of antibiotic variants.Economic evaluation of linezolid versus teicoplanin for the treatment of infections caused by gram-positive microorganisms in Spain.In Vitro Activities of LCB 01-0648, a Novel Oxazolidinone, against Gram-Positive Bacteria.Linezolid for the treatment of skin and soft-tissue infections
P2860
Q26995628-FF96A637-F23A-444D-AAC3-B50DA149EDC3Q33407349-33F3CC27-990C-4D17-857F-F90BB65A8F1DQ34090666-0A1ECADE-F074-4575-850F-06DA9F0FEF2DQ34584411-AF39355B-6C35-4BAE-A793-48FE1E2B9A1CQ34989916-35B44820-D455-4F4A-93A7-216930D36E4BQ35066619-243D82B8-FACF-4FE3-9894-3C8A0DEF90B7Q35215431-54303ADF-A580-4326-A788-205F7AA49102Q35296773-8ED4C60E-9A80-432D-B3D8-C37143E84DCAQ35867280-98154958-FA98-414B-986F-35E90C0FBACFQ36281035-EF0B7887-2E72-494E-8DA8-80B29E59AC0DQ36283744-06A8EF48-5D59-4334-98B8-D4376F6D42AAQ36458452-D5F34548-B091-420F-8540-BAD02586B89BQ36724345-8B462319-E675-43F6-92C2-5D93DF9B904DQ36839693-381664D5-A1FA-4D68-A1BA-8C35D22058DCQ36967288-BBB9E2E8-ABCE-4D0C-A8B5-31E7ECFDA697Q37041345-B531FA29-F4C1-46C3-874F-8049E40A062CQ37116859-D814F8B6-BB8E-4525-BA8A-DB4E53322AD0Q37268425-59F98B0E-DF3A-4752-95F7-E4603316B2F0Q37426237-492E5858-87A3-41CE-92AD-F5C28E4F1175Q37765900-3F9A31CA-A4D9-49C2-ABF0-908BC0420F52Q37785546-1C87E6CA-03CF-4390-AE14-8193DE494FE3Q38070154-0C389C74-225C-44BA-BE85-BF6F21F339CAQ38097374-F49A231C-F00A-4DBF-B897-E0A02AFDB81DQ38185097-624919C2-551D-4667-81F2-8035A55A29BDQ38929509-C4FDA590-D8E7-4DD8-883B-058990445B24Q40087530-D7A2DCB5-F0E4-4649-9208-095BD420B3F1Q41789967-1BDE8EBF-1C9C-47CF-805C-518F204D1C1AQ44115544-BDAE5948-4036-4211-AA6A-2CE68A09CD7BQ50855186-3450090F-CC8C-4F17-A931-3657D96AE5FBQ56268956-F3EFDC13-704A-49A8-99D3-A4C1AF3AF78D
P2860
A review of linezolid: the first oxazolidinone antibiotic.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A review of linezolid: the first oxazolidinone antibiotic.
@ast
A review of linezolid: the first oxazolidinone antibiotic.
@en
type
label
A review of linezolid: the first oxazolidinone antibiotic.
@ast
A review of linezolid: the first oxazolidinone antibiotic.
@en
prefLabel
A review of linezolid: the first oxazolidinone antibiotic.
@ast
A review of linezolid: the first oxazolidinone antibiotic.
@en
P2860
P356
P1476
A review of linezolid: the first oxazolidinone antibiotic.
@en
P2093
Brian Dotter
Dennis L Stevens
P2860
P356
10.1586/14787210.2.1.51
P577
2004-02-01T00:00:00Z